As of 06 Nov 2026 03:36 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2022/081 (30 Sep 2022): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Nafarelin (Synarel®) 200microgram/dose nasal sprayaffected product · inferred from phrasing | Out of stock, as stated | late-December 2022precision: late in the month · window end 31 Dec 2022, derived from “late-December 2022” | notice of 30 Sep 2022 |
| Buserelin (Suprecur®) nasal 150microgram/dose sprayaffected product · inferred from phrasing | Out of stock, as stated⚠ the source line states more than one status — first stated shown | late-December 2022precision: late in the month · window end 31 Dec 2022, derived from “late-December 2022” | notice of 30 Sep 2022 |
| Alternative gonadotrophin-releasing hormone (GnRH) analogues (parenteral formulations)class-level statement by the source, not a named product · inferred from phrasing | Stated as available | — not stated for this line | notice of 30 Sep 2022 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
The latest recorded notice names no alternative as remaining available.
Identifiers — Nafarelin
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Sep 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 30 Sep 2022. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 30 Sep 2022 | Medicine Supply Notification: Nafarelin (Synarel® ) 200microgram/dose nasal spray | Supply notification | Tier 2 | MSN/2022/081 |
Also recorded under
Bracketed names seen in this medicine's notice titles: synarel. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
No NHS Scotland Medicine Supply Alert Notice on record matches this name. Scotland is a separate record (all Scotland alerts); absence here is not a statement about supply in Scotland.